tiprankstipranks
Trending News
More News >
Nanobiotix SA (GB:0QAV)
LSE:0QAV

Compare Nanobiotix (0QAV) vs. Competitors

Compare
4 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Nanobiotix
€17.50
€880.63M
490.82%
1 Buy
0 Hold
0 Sell
Moderate Buy
Genfit
€5.36
€267.60M
-6.74
51.30%
1 Buy
0 Hold
0 Sell
Moderate Buy
Innate Pharma SA
€1.62
€145.99M
-2.79
-15.92%
0 Buy
1 Hold
0 Sell
Hold
Abivax SA
€99.20
€8.60B
-35.49
1369.63%
1 Buy
0 Hold
0 Sell
Moderate Buy
DBV Technologies
€2.96
€615.12M
-3.13
295.33%
1 Buy
0 Hold
0 Sell
Moderate Buy
OSE Immunotherapeutics SA
€5.02
€116.19M
-3.17
-26.39%
0 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
GB:0QAV
Nanobiotix
17.50
14.54
490.82%
FR:GNFT
Genfit
5.25
1.82
53.06%
FR:IPH
Innate Pharma SA
1.53
-0.28
-15.27%
FR:ABVX
Abivax SA
99.20
92.73
1433.23%
FR:DBV
DBV Technologies
2.97
2.09
238.86%
FR:OSE
OSE Immunotherapeutics SA
5.02
-1.73
-25.63%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts